Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prostacyclin receptor | ||
Ligand | BDBM464509 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | HTRF assay | ||
EC50 | 8.00±n/a nM | ||
Citation | Tran, T; Hayashi, R; Ibarra, JB; Ullman, B; Zou, N Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators US Patent US10793529 Publication Date 10/6/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Prostacyclin receptor | |||
Name: | Prostacyclin receptor | ||
Synonyms: | PGI receptor | PI2R_HUMAN | PRIPR | PTGIR | Prostacyclin (IP) Receptor | Prostacyclin receptor | Prostaglandin I | Prostaglandin I2 | Prostaglandin I2 receptor | Prostanoid IP receptor | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 40968.22 | ||
Organism: | Homo sapiens (Human) | ||
Description: | The membranes prepared from human platelet were used in binding assay. | ||
Residue: | 386 | ||
Sequence: |
| ||
BDBM464509 | |||
n/a | |||
Name | BDBM464509 | ||
Synonyms: | 2-(((1s,4s)-4-((6-(4- methoxyphenyl)-3-oxo-5- phenyl-1,2,4-triazin-2(3H)- yl)methyl)cyclohexyl) methoxy)acetic acid | US10793529, Compound 69 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H29N3O5 | ||
Mol. Mass. | 463.5256 | ||
SMILES | COc1ccc(cc1)-c1nn(C[C@@H]2CC[C@H](COCC(O)=O)CC2)c(=O)nc1-c1ccccc1 |r,wU:12.12,15.16,(-10,4.62,;-10,3.08,;-8.67,2.31,;-7.34,3.08,;-6,2.31,;-6,.77,;-7.34,,;-8.67,.77,;-4.67,,;-3.33,.77,;-2,,;-.67,.77,;.67,,;.67,-1.54,;2,-2.31,;3.33,-1.54,;4.67,-2.31,;6,-1.54,;7.34,-2.31,;8.67,-1.54,;10,-2.31,;8.67,,;3.33,,;2,.77,;-2,-1.54,;-.67,-2.31,;-3.33,-2.31,;-4.67,-1.54,;-6,-2.31,;-7.34,-1.54,;-8.67,-2.31,;-8.67,-3.85,;-7.34,-4.62,;-6,-3.85,)| | ||
Structure |